pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-642b |
Genomic Coordinates | chr19: 45674932 - 45675008 |
Description | Homo sapiens miR-642b stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-642b-3p | |||||||||||||||||||||||||||
Sequence | 47| AGACACAUUUGGAGAGGGACCC |68 | |||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||
Experiments | Illumina | DRVs in miRNA |
|
|||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | LARP4B | ||||||||||||||||||||
Synonyms | KIAA0217, LARP5 | ||||||||||||||||||||
Description | La ribonucleoprotein domain family member 4B | ||||||||||||||||||||
Transcript | NM_015155 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on LARP4B | |||||||||||||||||||||
3'UTR of LARP4B (miRNA target sites are highlighted) |
>LARP4B|NM_015155|3'UTR 1 AAACCGTACGTCTGGGAGGGGTCGCAGAGCGCTGTGTTAACCACAAACGAGACACTCTCCCACTCAGTGCGAGGGCGAGC 81 CGCTGGTTAGGAGCTTGCAGTGTCTGAGGCCTGTGGGATCCTCAAGTTGGTTTTCTTCTGTGAGTTGGATTCTCCCCCTC 161 TTGAAAAAAAATCGATTTTTCAGGATTTAATTAATACAAACCTTATTTTAGGTTGGTGCTTAACTGGAGGTGATGCATAA 241 GTCTGATTTTTTTTTCCAAGATAGAAAAAGCATTTATCCTAACAAATTGGTATTTTTTATTAAGCCTCCATGTGGCTCTG 321 AATGCAAGCTATATATAGTGAGTTTTTCTAAATTAAGGGAACTCTGCTTTTTTTTTTTTTTTTTAAGTAACTGGTCTGTA 401 AGTGCATATCTCTAGAACGTCCCCGCAGATGAATGAGGGCCAGTGGCCTTGGCAGAGGCAGGTGTGGCCTCGTAGAGGCA 481 GTGCTGGCCGCGCCAGGGCATCAGTGCTGATGTGGGAGCTGTGCTTCCACCTAAGCCGTTGGTAGGGGACTGTGGCATTT 561 AAGAATGTAGAGAGCGCATCCTTTTTGATCTCCTGGGCGGAGTGAACCTGCAGGGGCCACCCCAGAAACCTTGGTTCTGA 641 TGCACTGCAAGCAAGTAACCAGCTTCTCACTCCAGTTTCAAGTGGCTATTATGTAATATAAATTCAAAGCACATTGTGAA 721 TAGAACCTACATGAAAACATACACTTTGTTGCCCACTGACATGTTACCAGAAGTTGTACCATGATGTTGTTTTGACCCCT 801 GTGAGCTGATGGCCCCGGCCCTGCTCTGTGCACATTTCTGTCCGTGTTCCCCAGCACTCTGGTTGGAGAGAGTCCACATC 881 TTCAGCTCCGTGTGGACATCTCCCTGTACCTCTGCATCAGCACATGGATTTAAGAGTTATGTAATCGTGAGAGAATGGTG 961 TTTGTGGTTTTTCCCCCTCTTTGGCTGGTGGAGGATAAAGTTCCTGCTCTTTTACCTCCAAGACGAGGGCCTCATTGATT 1041 CACTTCCAGAAGTGCTGCACTTCTGAAGAACAAGGATGCACTAAAGTTAGCAAGTTTATAATAAAGTTAAATATAAATTA 1121 TTTTGTTTTAAAATGCCTCAAATTTTTCTTTATTCTAAGCAGCAAACATTAAAATAAGAATATTTCCTGCTAAATGTAAC 1201 CATACACTTTATTCCACAAAATGTTATTTAACAAGACTGAGGGTTTTTTTTAAGAAAAAATTATTTCCATCCAATATTTA 1281 AAGACTTGAATTTTATTTAAACTTGAAAATGACTTTGCCTTAACTTTTGTATAAGACAGCTTAGAGTCCATGGAGCCCGG 1361 CCCTGGGTTGGCGTGAGTGGGTCAGAGTTACTCAGTTACTGCGTGGATCTCCTGTCGCTAGTTTTACTGAGTAAGCATAC 1441 TGTAGTACAAGAGCTAGTAGTAGTTTTTGTAATATACCTTAAAGATCTTCAACAGTTGATCTTTTTTCAGAATGTTGGAA 1521 AATCCTGTAAATGCAAATAGTCAATACTGTATTAAATACGTGCACTTGGAGTGTGCTTCGCTTGTACAGTTGTAAATAAT 1601 CAGAACATATGAAAAAGGTACCCTACAGAGAAAATTCTGATACAGATTATTGATATATTATAAATGTTGCTGTTGAGCGG 1681 GATGTAGATAAACTAAATGTTGTGGTTTGAATATTATTTTGATTTGTTGAGATTTTCTTTTTTCTCTTACATCGGTGTGT 1761 TGAACTGATTCTGCCTCTTTGCTGCAAAAGGGAATTGGAAAGTCTTATTAAAAGCCTCCAGATGTTTTCATACTCTTTTA 1841 AAATGTATGTAAATGCATACTAATCATATCTAATGTGAAAGAGTTTTAAAGTATATAGAGAGCAAAAACTGGCAGGATCG 1921 TAAGTGAAGGTGACTAGTAATCTAATTTAAATCACCTGCAGCTAAGCATGATTGACCCTGCCAGAGGAAAACATGCCTAT 2001 TTGACCATTTCCTTTAAAGCAGTTGCCATTATTCAAATACAGAGAAATAGCCACAGGGCTAGTGTTTTTCAAATGCATTT 2081 TAAAGAACATGGGGATTTTTTTTTGTAGTTGTCAGTTCACTGACCAAAAAAAAAAAAAAAATCAGAAATAATTGATCTGT 2161 GAAACCCAAACTCTCAATACTCAGAAAGCTGGGAGGCAACCTCGAGGCCTGGGCCTACGAGCTGCATCTTCGCTACGGAA 2241 GGGCCAGGGCGCCATCAGCCATTCCCAAAACACAAGGCCTGCCCGTCCGCCAGTGAGTCCTTGGTTTTTAATAATGAGAA 2321 GTCCTTTCCCCCAAGGTGTGAGCATTGCAGCGCAGTGTGTGTGTGTGGTTAGAGCCAGCTTAGTCCTTCACTTTGTCGAC 2401 CGAAGTGGGAGCTCAACAGCTGCATGAGGAGGGCAGCGCGTGCATTAGCCAGTCGCCACTGGAGGGCTCTGCTGCCCTCC 2481 GGTCAATACACTGTAGTTACTGCCTAGCCAGCAGCAGTCTTCTGCATCAAGAACTGAAACGTTGCTCGGAGGTGATTTTT 2561 ATAGCATCCTTTTTAATTAAAGGTGAAATACAGATTGCTATATAATGTCTGAAAAAACCTGATACTACTTCAAGAGTTTC 2641 TGCTCAGAAGAAAATGAGAGTTATCATAATAGGAAGCTGTGGCGGTCCATGCCAACTGTGCTGTGTCACATACAGCGATG 2721 AGAGTGGCTTTCATACTTTTTTTTTTTTTAAGTTAACACCCTCCTTTACCCCCAGCAGTATCTCAGGTTATAGAATCAGA 2801 GATGCAGCAGTGACAAATGGCATTTTAACTTGTAAAATCGTGTGATGATGCTTATCATTTTGAAATAGAAGAATAAAAAC 2881 CTGGTCCCGTTTCACCAGACATGAATTTCAAGTGGAGTCGTCGTTCTCTGAGAGTGAGTGTCTTGACATTTTCACCCAGG 2961 CCCTCCTGTCATCACATCACCGGCTGTCACTGGCGGGTGGCCGTAAACGTCCTGCGTTGCTATATTAGGATCTCTGCAGT 3041 TCAGGCTTCAAAACCAGTTCAGTGTATCCGGGCGACGGGTAGTGGTGGTGCATGCCTGTCTGTGTGCCCCGCTGGCGAGC 3121 TGTAGTTGCGGCTTGCGTGCCTCGCGGCCCACTACAGGGCTGCAGACAATCGAGGCGAGGGCGCTGGCCGCCAGCAGCTC 3201 ACAGCGCGGGGGTCATGTGGTCGCTCCTCGAGGGTTTCGTTTTTGTTCTGCTTCATTAAGACTGGAATCAAGCTTACATG 3281 TAAACTATTGGTAATTTAAGTTTCCTTTTGTGTCATTCAGTGTAAAACTGTCTAATTTGAAAAAAAATGTAGGTTATGAA 3361 AATAAAGATTTAGGCACTGTTCAATTTTTCTTTTGATTTTTTTTAAATTAAAATTTCTTCAATAATGCATCTTTTCTAAA 3441 CATAGTTTTTTGTCTGTTCCCATAAGTGCATGAGAAAGAAACACGGGCCTCATATATGATTGGATCCTAAAGCCTTCTCA 3521 CCTACGTGGGGGCTGGCTGTGGCACACGGGGCTCACCCTTTGTGTTTTAGTGGTTCAGAGTGAGCATTAACATCAGATGC 3601 TCATGCGGAGACAGCCATTACTGTGACTGCCAAGATGTACTGCAAAAATACATGTTCCTGTATCAGGACTTTGATTTTGT 3681 TAAAATGGCACTCTCTCCAAAGCTGTGTCCATGAAGCTGTTTGGAGCTAACGTTGGGTCTTCATGGTGATGGACTCATCC 3761 TTAGGCAGCAGTGATGTCTGCACTAGGAAGAGGCTGGCGGGAGGCGGGGCCCCTCCTGTGCCAGGCACCGAGTGGATGGG 3841 GGACTGATTAACATGTTGCTGCCTTCCTCCTCTGTGCATTGCCTTTTCATGTCGTCTTCCCATTTTTACTCTTTTTCTGA 3921 TGGAATTAATATTCTTGATCTGTTAAGGCTATTAATCCTTTGTCATATATGTTACAAATATTTTCTTTCAATCTACCATT 4001 TGTCTTAACTCTTTATTTAGAATAGTATCTTTTACGGTGTTTAATTATTGTGTAGTAAAATCTATCAATCTTCTCCTTTG 4081 TTGAGTGTCTTGGACTTGCTTAAGAAGCCTTTCCCTACTCCAGGGTCATAAAGTTAATAGTGTGTGTGTATGTGTGCGTG 4161 TGTGTGTGTGTGTGCGTGCACACGCACACACACACACACACGCTTTTAATCCAGCTGGGCCTAATCGTGTGTGTGGTGTG 4241 CGTGCTTAGGCAGGAACCCAGTTTTACTTTATGCCATGTGGAAAGTTTCTTTTTCCAGTATCACCAGTGAGTTCACTGTC 4321 TCTCCACTGGTCTGCAGTGCTGCTTCTGTTACTTGCAGACTTCCCACGTGTGCATGGATCTCCACCTGGGGTCTCTAGGG 4401 TCTCTATTCTACACTGCCTATTTCCCTTTCTGTCCTAACACCATAGCATTTAACTCACCCGTCATCCTGTGTTGCTGAGA 4481 ATTTCCTTCATAGAACTCATCAAAGTATGATTAACTGTGCTCCCTGAGGGCAGGAATTATGCCATCTGGATCACCAGCCT 4561 CTCCCTTGTCCTTAGCACGCCATCTGCAAATTAGCAGATACTCGGTAAATGTGTATTAACTCGAAGTATATTTTGTGTCT 4641 TCTCTGTGCACAGCACTGCCCTGGGAAGAACTAGGATGAGGTATTGACTTGCTGTTGCCACATAACAAACCCTGCCAGAA 4721 CTCCCTGGATGGAAGTGACCACCGTGTATCTGTGGATTGTCTGCAGGGCTCTGCTGGGGTCAGCAGGTCCCACAAGAGAG 4801 CCAGGGCTCGGTCTCCTCATGGCTGTCAGAGGTTTACGTATTCCGCCTCCACCCACCAAAGTCTGAAGTTGTTGTATTCC 4881 ATTCCTTGCTATATCCACATCTTTTAATAATGCTAAAATCCCGTGTTTCTCTAAAGCATTGGATTGAACCAACTGAAGAA 4961 GGACCACGTGTGTTGCTGGGCCTGCTTGGGCACAAGCCGTTTCCGATCCAAGTCAACTGCTGGTCTGCTTAGACGAAGGT 5041 GTGTGGGTGTCTCCACCACGGAGAGGAGGGACAGCAGGTGAGACCATAGGCCAGGAAGGAAGGGCACAGCCTAAGCGTGC 5121 AGTGGCTTAGCCAGAGACCCTCGTGCACCAGCCTTCAGGTGCTTATGGAACTTATGTCAGCCCAGGCCATATCCAAGTGT 5201 GTGATGTCTCGGAGCATATATGCCAGGCCAGCCGGAGAGGCTTAGCCCTGCCCTGGTGGAGCTGGAGGGCCGCAGGGCCG 5281 CCCGGTGGGGTCAGGAGGTTGTGAAGAGGATCCTGATACAGGCTGGGCCTCCCTGCAGGCGTGAGCCCCGGAGCACGGGG 5361 TGAGCAGCTCCACCCAGAGGGGCTTGCAGGACCAAGCTGGGACAGCAACCACCAGGCCCTGGGGCAGATCAGTGAGCGTC 5441 CAGGAGATGCAGATGCAGAAGACAGCCAAATTCATTCACCTCTGCGTGGGCCTGTGAGGGCCCACAGAGATGCATTTTCA 5521 TTCACGACCAGGATTTCCTCGGCCGGAGCAGCCGCTTTTCCCAGCCGAAGCTCACTGTGTTTACTACATAGGATGTGAGT 5601 GTATAGAAAGACTCTCTCTAACGTTAGCTACGCGTGCAGAAATGTGGGGCGCTTACAAGTGTGGGCAGCCGCAGCCTGTT 5681 CCTCACCCCTGTCCTAACGGGACATACTCCACGCATGCACATTTAGGATCACCGTGTCTTCTCGTTGGACTGATCTGTCA 5761 TTAGGACCCTGGACCCAAGTAATTGTCTTTGCTCTGAAGTTTTGACAGTAACAAAGGCATTCCAGCTCTTTCTTTTTCAC 5841 TCCTGTCGGTGTAACGTGCCGTTTTTCATCCTTTGACTTTTAGCCCGCCTGTGCCCTGTCTGAAGGGAGTTGTCTGTGGA 5921 CAGCACGGAGTGGTGGGTGTTTGTAATCCACTCTGCCAGCCTCAGTCTTCTAACTGTTGCGTATGGACCAATTACATCTG 6001 CCCTTTCTCTTC Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462573. RNA binding protein: AGO2. Condition:TZM-bl BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462573 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl BaL |
Location of target site | ENST00000316157.3 | 3UTR | UCCAUGCCAACUGUGCUGU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
77 hsa-miR-642b-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT082888 | ZNF543 | zinc finger protein 543 | 2 | 2 | ||||||||
MIRT108294 | BHLHB9 | basic helix-loop-helix family member b9 | 2 | 2 | ||||||||
MIRT348737 | ZNF350 | zinc finger protein 350 | 2 | 2 | ||||||||
MIRT381384 | EXOG | exo/endonuclease G | 2 | 2 | ||||||||
MIRT452245 | TRAM1 | translocation associated membrane protein 1 | 2 | 2 | ||||||||
MIRT459262 | ADRBK1 | G protein-coupled receptor kinase 2 | 2 | 2 | ||||||||
MIRT468117 | SH3PXD2A | SH3 and PX domains 2A | 2 | 2 | ||||||||
MIRT468402 | SETD3 | SET domain containing 3 | 2 | 2 | ||||||||
MIRT469079 | RNF168 | ring finger protein 168 | 2 | 2 | ||||||||
MIRT471690 | OXR1 | oxidation resistance 1 | 2 | 2 | ||||||||
MIRT477353 | EOGT | EGF domain specific O-linked N-acetylglucosamine transferase | 2 | 4 | ||||||||
MIRT479600 | CDC25B | cell division cycle 25B | 2 | 2 | ||||||||
MIRT482377 | AFF4 | AF4/FMR2 family member 4 | 2 | 4 | ||||||||
MIRT484029 | LARP4B | La ribonucleoprotein domain family member 4B | 2 | 2 | ||||||||
MIRT490988 | USP22 | ubiquitin specific peptidase 22 | 2 | 2 | ||||||||
MIRT493250 | MEF2D | myocyte enhancer factor 2D | 2 | 2 | ||||||||
MIRT493850 | FOXN3 | forkhead box N3 | 2 | 4 | ||||||||
MIRT496086 | C17orf85 | nuclear cap binding subunit 3 | 2 | 2 | ||||||||
MIRT500630 | TXNIP | thioredoxin interacting protein | 2 | 2 | ||||||||
MIRT501048 | SMEK1 | protein phosphatase 4 regulatory subunit 3A | 2 | 2 | ||||||||
MIRT525186 | ZNF257 | zinc finger protein 257 | 2 | 4 | ||||||||
MIRT534875 | QSER1 | glutamine and serine rich 1 | 2 | 2 | ||||||||
MIRT539336 | AGPAT5 | 1-acylglycerol-3-phosphate O-acyltransferase 5 | 2 | 2 | ||||||||
MIRT553814 | SYNCRIP | synaptotagmin binding cytoplasmic RNA interacting protein | 2 | 2 | ||||||||
MIRT555959 | NRAS | NRAS proto-oncogene, GTPase | 2 | 2 | ||||||||
MIRT556289 | MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 2 | 2 | ||||||||
MIRT561212 | ZSWIM1 | zinc finger SWIM-type containing 1 | 2 | 2 | ||||||||
MIRT567328 | HMGB1 | high mobility group box 1 | 2 | 2 | ||||||||
MIRT572385 | LRRC6 | leucine rich repeat containing 6 | 2 | 2 | ||||||||
MIRT575529 | Map4 | microtubule-associated protein 4 | 2 | 2 | ||||||||
MIRT575684 | Map1b | microtubule-associated protein 1B | 2 | 2 | ||||||||
MIRT576828 | Tgfbr3 | transforming growth factor, beta receptor III | 2 | 2 | ||||||||
MIRT576953 | Pigs | phosphatidylinositol glycan anchor biosynthesis, class S | 2 | 3 | ||||||||
MIRT608316 | SYK | spleen associated tyrosine kinase | 2 | 4 | ||||||||
MIRT609794 | PINX1 | PIN2/TERF1 interacting telomerase inhibitor 1 | 2 | 2 | ||||||||
MIRT609991 | PIGS | phosphatidylinositol glycan anchor biosynthesis class S | 2 | 3 | ||||||||
MIRT611381 | PNMAL1 | paraneoplastic Ma antigen family member 8A | 2 | 4 | ||||||||
MIRT613566 | YY2 | YY2 transcription factor | 2 | 2 | ||||||||
MIRT614612 | MVK | mevalonate kinase | 2 | 2 | ||||||||
MIRT615497 | MPP2 | membrane palmitoylated protein 2 | 2 | 2 | ||||||||
MIRT616941 | OTUD7A | OTU deubiquitinase 7A | 2 | 2 | ||||||||
MIRT617576 | NDUFB5 | NADH:ubiquinone oxidoreductase subunit B5 | 2 | 2 | ||||||||
MIRT618214 | SPTLC3 | serine palmitoyltransferase long chain base subunit 3 | 2 | 4 | ||||||||
MIRT619885 | ABHD17B | abhydrolase domain containing 17B | 2 | 2 | ||||||||
MIRT620401 | MYO1H | myosin IH | 2 | 2 | ||||||||
MIRT620517 | SNRPD1 | small nuclear ribonucleoprotein D1 polypeptide | 2 | 2 | ||||||||
MIRT622166 | SMYD1 | SET and MYND domain containing 1 | 2 | 2 | ||||||||
MIRT623195 | MTX3 | metaxin 3 | 2 | 2 | ||||||||
MIRT623440 | KIAA0408 | KIAA0408 | 2 | 4 | ||||||||
MIRT624837 | ACAP2 | ArfGAP with coiled-coil, ankyrin repeat and PH domains 2 | 2 | 2 | ||||||||
MIRT625706 | SHROOM1 | shroom family member 1 | 2 | 2 | ||||||||
MIRT628159 | HIP1 | huntingtin interacting protein 1 | 2 | 2 | ||||||||
MIRT629496 | SGIP1 | SH3 domain GRB2 like endophilin interacting protein 1 | 2 | 2 | ||||||||
MIRT630240 | SOGA3 | SOGA family member 3 | 2 | 4 | ||||||||
MIRT630521 | BAZ2A | bromodomain adjacent to zinc finger domain 2A | 2 | 4 | ||||||||
MIRT635676 | COX18 | COX18, cytochrome c oxidase assembly factor | 2 | 4 | ||||||||
MIRT637820 | CACNA1B | calcium voltage-gated channel subunit alpha1 B | 2 | 2 | ||||||||
MIRT637943 | SIGLEC9 | sialic acid binding Ig like lectin 9 | 2 | 2 | ||||||||
MIRT640490 | EXOC5 | exocyst complex component 5 | 2 | 2 | ||||||||
MIRT642722 | ATXN3 | ataxin 3 | 2 | 2 | ||||||||
MIRT649153 | LRTM1 | leucine rich repeats and transmembrane domains 1 | 2 | 2 | ||||||||
MIRT649610 | ITPKC | inositol-trisphosphate 3-kinase C | 2 | 2 | ||||||||
MIRT661016 | ABCA12 | ATP binding cassette subfamily A member 12 | 2 | 2 | ||||||||
MIRT661055 | RPL18A | ribosomal protein L18a | 2 | 2 | ||||||||
MIRT684041 | FOLR1 | folate receptor 1 | 2 | 2 | ||||||||
MIRT691014 | CRTC3 | CREB regulated transcription coactivator 3 | 2 | 2 | ||||||||
MIRT698908 | SPPL2A | signal peptide peptidase like 2A | 2 | 2 | ||||||||
MIRT700981 | PDE4D | phosphodiesterase 4D | 2 | 2 | ||||||||
MIRT701722 | MTMR12 | myotubularin related protein 12 | 2 | 2 | ||||||||
MIRT702724 | INSIG1 | insulin induced gene 1 | 2 | 2 | ||||||||
MIRT705057 | C5orf15 | chromosome 5 open reading frame 15 | 2 | 2 | ||||||||
MIRT705216 | BRWD1 | bromodomain and WD repeat domain containing 1 | 2 | 2 | ||||||||
MIRT706088 | HNRNPU | heterogeneous nuclear ribonucleoprotein U | 2 | 2 | ||||||||
MIRT709458 | KRTAP19-1 | keratin associated protein 19-1 | 2 | 2 | ||||||||
MIRT711396 | RANBP2 | RAN binding protein 2 | 2 | 2 | ||||||||
MIRT720573 | SDHAF2 | succinate dehydrogenase complex assembly factor 2 | 2 | 2 | ||||||||
MIRT725366 | MTF2 | metal response element binding transcription factor 2 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|